Royal Bank of Canada’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+85
| New | – | ﹤0.01% | 6982 |
|
|
2024
Q3 | – | Sell |
-404
| Closed | -$7K | – | 7062 |
|
|
2024
Q2 | $7K | Buy |
404
+352
| +677% | +$6.1K | ﹤0.01% | 6071 |
|
|
2024
Q1 | $1K | Sell |
52
-608
| -92% | -$11.7K | ﹤0.01% | 6444 |
|
|
2023
Q4 | $10K | Buy |
660
+288
| +77% | +$4.36K | ﹤0.01% | 5966 |
|
|
2023
Q3 | $18K | Buy |
372
+182
| +96% | +$8.81K | ﹤0.01% | 5727 |
|
|
2023
Q2 | $15K | Buy |
190
+98
| +107% | +$7.74K | ﹤0.01% | 5880 |
|
|
2023
Q1 | $8K | Sell |
92
-63
| -41% | -$5.48K | ﹤0.01% | 6041 |
|
|
2022
Q4 | $18K | Buy |
155
+138
| +812% | +$16K | ﹤0.01% | 5882 |
|
|
2022
Q3 | $3K | Sell |
17
-4
| -19% | -$706 | ﹤0.01% | 6446 |
|
|
2022
Q2 | $2K | Sell |
21
-71
| -77% | -$6.76K | ﹤0.01% | 6549 |
|
|
2022
Q1 | $14K | Sell |
92
-193
| -68% | -$29.4K | ﹤0.01% | 6319 |
|
|
2021
Q4 | $85K | Buy |
285
+159
| +126% | +$47.4K | ﹤0.01% | 5523 |
|
|
2021
Q3 | $73K | Buy |
126
+19
| +18% | +$11K | ﹤0.01% | 5417 |
|
|
2021
Q2 | $48K | Buy |
107
+4
| +4% | +$1.79K | ﹤0.01% | 5582 |
|
|
2021
Q1 | $56K | Buy |
103
+75
| +268% | +$40.8K | ﹤0.01% | 5323 |
|
|
2020
Q4 | $25K | Sell |
28
-661
| -96% | -$590K | ﹤0.01% | 5418 |
|
|
2020
Q3 | $436K | Buy |
+689
| New | +$436K | ﹤0.01% | 3531 |
|